APP and Alzheimer disease: The tau hypothesis assigns the AD molecular mechanism trigger to impairments of APP metabolism with subsequent accumulation of APP C-terminal fragments and development of tau pathology (tau aggregation, formation of paired helical filaments and NFTs) [67].